Striving towards the elimination of HCV infection, Berlin 2018

Kongressthemen
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV. The WHO has set an ambitious goal to eliminate HCV as a major public health threat by 2030.

Kongressorganizer (PCO)
Evvnt Promotion / evvnt

Anmerkungen
Url:

Booking: https://go.evvnt.com/147888-1

Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely

EASL The Home of Hepatology